Jurgimeda - Company finances
|
EUR
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|
|
Financial data
|
||
| Sales revenue | 70,181 | 71,947 |
| Profit before tax | 17,167 | 12,057 |
| Net profit | 16,309 | 11,334 |
| Equity | 22,401 | 33,735 |
| Liabilities | 6,004 | 5,869 |
| Non-current assets | 0 | 0 |
| Current assets | 28,405 | 39,539 |
| Total assets | 28,405 | 39,539 |
|
Taxes paid
|
||
| STI taxes | - | 858 |
|
Financial indicators
|
||
| Revenue change y/y | - | +2.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 57.4% | 28.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 72.8% | 33.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 23.2% | 15.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 24.5% | 16.8% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.3 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Jurgimeda - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-09-03 | 2024-10-31 | 193.50 |
| 2024-08-01 | 2024-09-02 | 129.00 |
| 2024-07-02 | 2024-07-31 | 64.50 |
| 2024-06-03 | 2024-06-30 | 193.50 |
| 2024-05-02 | 2024-06-02 | 129.00 |
| 2024-04-03 | 2024-05-01 | 64.50 |
| 2024-03-01 | 2024-03-31 | 129.00 |
| 2024-02-01 | 2024-02-29 | 64.50 |
| 2024-01-03 | 2024-01-31 | 175.89 |
| 2023-12-01 | 2024-01-02 | 117.26 |
| 2023-11-03 | 2023-11-30 | 58.63 |
Jurgimeda - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-07-01 | 2025-07-31 | 2.53 |
| 2025-06-28 | 2025-06-28 | 858.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Jurgimeda, MB (company code 306391256) is a small partnership active in traditional, complementary and alternative medicine activities. In the latest financial year, 2025, the company generated revenue of €71.9K, up 2.5% year on year from €70.2K in 2024. Net profit for 2025 was €11.3K, compared with €16.3K in 2024, while profit before tax declined from €17.2K to €12.1K. As a result, the net profit margin decreased from 23.2% in 2024 to 15.8% in 2025, showing that profitability softened despite modest sales growth. Over the two-year period, the business increased its balance sheet size: total assets rose from €28.4K to €39.5K, and equity increased from €22.4K to €33.7K. Liabilities remained low and stable at €5.9K in 2025, compared with €6.0K a year earlier. For 2025, the company posted a return on equity of 33.6%, return on assets of 28.7%, a debt-to-equity ratio of 0.17, and asset turnover of 1.82x, indicating efficient use of its asset base.